Neoplasms by Site

Subtype terms (17)

More specific conditions that are subtypes of Neoplasms by Site in the MeSH hierarchy.

• Abdominal Neoplasms

  33 drugs (27 approved, 6 experimental)

• Anal Gland Neoplasms
• Bone Neoplasms

  45 drugs (31 approved, 14 experimental)

• Breast Neoplasms

  2017 drugs (591 approved, 1426 experimental)

• Digestive System Neoplasms

  87 drugs (39 approved, 48 experimental)

• Endocrine Gland Neoplasms

  17 drugs (11 approved, 6 experimental)

• Eye Neoplasms

  8 drugs (4 approved, 4 experimental)

• Head and Neck Neoplasms

  628 drugs (243 approved, 385 experimental)

• Hematologic Neoplasms

  339 drugs (162 approved, 177 experimental)

• Mammary Neoplasms, Animal

  1 drug experimental

• Nervous System Neoplasms

  7 drugs (4 approved, 3 experimental)

• Pelvic Neoplasms

  17 drugs (14 approved, 3 experimental)

• Skin Neoplasms

  164 drugs (98 approved, 66 experimental)

• Soft Tissue Neoplasms

  10 drugs (9 approved, 1 experimental)

• Splenic Neoplasms
• Thoracic Neoplasms

  47 drugs (34 approved, 13 experimental)

• Urogenital Neoplasms

  72 drugs (43 approved, 29 experimental)

Drugs by status

Organizations